ADGRB1 and ovarian cancer: In addition to ADRB1, BRCA1-deficient ovarian cancer cells also express high levels of other factors related to catecholamine-adrenoceptor-cAMP pathway regulation, such as the adenylate cyclase ADCY2 and G protein-coupled receptor ADGRB1.